本文已被:浏览 962次 下载 620次
投稿时间:2018-09-16 网络发布日期:2019-06-20
投稿时间:2018-09-16 网络发布日期:2019-06-20
中文摘要: 目的 探讨不同治疗模式对食管鳞状细胞癌患者预后的影响。方法 回顾性分析2010年1月至2015年12月367例治疗的食管癌患者的临床资料,通过采取门诊和电话随访,共随访347例,统计患者生存时间,收集性别、年龄、治疗模式、病变部位、分化程度、病变长度、脉管癌栓、神经侵犯、TNM分期等预后影响因素,通过Cox回归分析法和Kaplan-Meier法分析食管癌患者生存率变化的影响因素。结果 单因素分析显示,单纯手术、手术+化疗、手术+放疗、手术+放疗+化疗治疗的3年生存率分别是51.9%、73.9%、74.5%、61.6%,单纯手术组3年生存率显著低于术后综合治疗组(P<0.05)。治疗模式和TNM分期是影响食管癌患者3年生存率的主要因素(P<0.05);Cox回归多因素分析显示,治疗模式和TNM分期是影响食管癌患者预后的独立影响因素(P<0.05)。结论 食管癌术后患者建议行综合治疗,治疗模式和TNM分期是影响食管癌患者生存的独立影响因素。
中文关键词: 食管癌 鳞状细胞癌;手术治疗 放射治疗 化学治疗 预后因素
Abstract:ObjectiveTo investigate the effects of different treatment modes on the prognosis of patients with esophageal squamous cell carcinoma(ESCC). Methods A retrospective analysis was made on 367 ESCC patients treated from January 2010 to December 2015.The survival time of 347 patients was counted through outpatients and telephone follow-up.The prognostic factors such as gender,age,treatment mode,lesion location,differentiation degree,lesion length,vascular tumor thrombus,nerve invasion,TNM stage were collected,and the influencing factors of survival rate changes were analyzed by Cox regression analysis and Kaplan-Meier method. Results Univariate analysis showed that the 3-year survival rates were 51.9%,73.9%,74.5%,61.6% in surgery alone group,surgery plus chemotherapy group,surgery plus radiotherapy group,surgery plus radiotherapy and chemotherapy group,respectively.The 3-year survival rate of simple surgery group was significantly lower than those of comprehensive treatment groups (P<0.05).Cox regression multivariate analysis showed that treatment mode and TNM staging were the independent influencing factors of prognosis in patients with esophageal cancer (P<0.05). Conclusion Comprehensive treatment is recommended for patients with esophageal cancer,and treatment mode and TNM staging are the independent influencing factors of patient′s survival.
keywords: Esophageal carcinoma Squamous cell carcinoma Surgery Radiotherapy Chemotherapy Prognosis factor
文章编号: 中图分类号: 文献标志码:A
基金项目:江苏省卫计委面上项目(H201303);南京市科技局项目(201611005)
附件
作者 | 单位 |
唐羽1 | 1.南京医科大学第一临床医学院,江苏 南京 210029 |
刘锦源2 | 2.南京医科大学第一附属医院胸外科,江苏 南京 210029 |
周悦2 | 2.南京医科大学第一附属医院胸外科,江苏 南京 210029 |
丁梦琪1 | 1.南京医科大学第一临床医学院,江苏 南京 210029 |
骆金华2 | 2.南京医科大学第一附属医院胸外科,江苏 南京 210029 |
Author Name | Affiliation |
TANG Yu*,LIU Jin-yuan,ZHOU Yue, | *The First Clinical Medical College of Nanjing Medical University,Nanjing,Jiangsu 210029,China |
DING Meng-qi,LUO Jin-hua | |
引用文本:
唐羽,刘锦源,周悦,等.食管鳞状细胞癌不同治疗模式的疗效分析[J].中国临床研究,2019,32(6):743-746.
唐羽,刘锦源,周悦,等.食管鳞状细胞癌不同治疗模式的疗效分析[J].中国临床研究,2019,32(6):743-746.